Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Nasdaq Inc (NDAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Nasdaq Inc — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while Nasdaq Inc trades at $92.64 (market cap $51.40B). The key difference: Nasdaq Inc is far larger — about 12.8× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Nasdaq Inc pays a 1.26% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Nasdaq Inc for 126 Days on average.
| INDV | NDAQ | |
|---|---|---|
Market Cap | $4.03B | $51.40B |
Volume | 2,781,171 | 3,601,938 |
Sector | Health | Financials |
52-Week High | $41.83 | $100.98 |
52-Week Low | $24.09 | $76.85 |
Typical Hold Time | 0 Days | 126 Days |
Enterprise Value | $4.32B | $57.86B |
Dividend Yield | — | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nasdaq (NDAQ) trades at $93.48, down 0.86% on the day, with strong technical momentum showing a bullish moving average signal despite overbought RSI conditions. The company demonstrates robust fundamentals with 2025 revenue of $8.26B and net income of $1.79B, representing a 21.64% profit margin. Recent earnings beats and the launch of AI-powered Calypso platform highlight operational strength. Analyst consensus remains strongly bullish with a $110.43 price target, representing 18% upside potential from current levels.
NDAQ presents a compelling investment case with consistent earnings outperformance, strong profitability metrics, and strategic AI integration driving growth. However, elevated valuation multiples (P/E 27.25) and potential market volatility from exchange operations pose risks. The stock's technical positioning near resistance at $95 requires monitoring, but institutional support and positive analyst sentiment suggest continued upside potential for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Nasdaq Inc
Founded in 1971, Nasdaq is primarily known for its equity exchange, but in addition to its market-services business (about 35% of sales), the company sells and distributes market data as well as offers Nasdaq-branded indexes to asset managers and investors through its information-services segment (30%). Nasdaq's corporate-services business (20%) offers listing services and related investor relations products to publicly traded companies and through the company's market technology group (15%), Nasdaq facilitates the exchange operations of other exchanges throughout the world and provides financial compliance services.
Read more on NDAQ →
